On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently ...

CVS Health (NYSE:CVS) is scheduled to announce Q4 earnings results on Wednesday, February 12th, before market open. Analysts expect a profit of $0.92 (-56.6% Y/Y) on revenue of $96.88B (+3.3% Y/Y).

Piper Sandler lifted their target price on CVS Health from $72.00 to $74.00 and gave the company an “overweight” rating in a research note on Friday, March 21st. Edward Jones raised shares of ...

Canoe Financial LP has opened a new $94.1M position in $CVS, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2025 report period ...